BIO
Price
$280.95
Change
-$9.83 (-3.38%)
Updated
Apr 18, 6:59 PM EST
6 days until earnings call
WST
Price
$377.35
Change
-$0.09 (-0.02%)
Updated
Apr 18, 6:59 PM EST
6 days until earnings call
Ad is loading...

Compare trend and price BIO vs WST

Header iconBIO vs WST Comparison
Open Charts BIO vs WSTBanner chart's image
Bio-Rad Laboratories
Price$280.95
Change-$9.83 (-3.38%)
Volume$106.53K
CapitalizationN/A
West Pharmaceutical Services
Price$377.35
Change-$0.09 (-0.02%)
Volume$49.32K
CapitalizationN/A
View a ticker or compare two or three
BIO vs WST Comparison Chart

Loading...

BIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
WSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BIO vs. WST commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and WST is a StrongSell.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (BIO: $281.02 vs. WST: $377.33)
Brand notoriety: BIO and WST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 177% vs. WST: 60%
Market capitalization -- BIO: $9.79B vs. WST: $28.97B
BIO [@Medical Specialties] is valued at $9.79B. WST’s [@Medical Specialties] market capitalization is $28.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileWST’s FA Score has 1 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • WST’s FA Score: 1 green, 4 red.
According to our system of comparison, WST is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while WST’s TA Score has 5 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 5 bearish.
  • WST’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, WST is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical Specialties) experienced а -9.89% price change this week, while WST (@Medical Specialties) price change was -2.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.63%. For the same industry, the average monthly price growth was -3.78%, and the average quarterly price growth was +9.66%.

Reported Earning Dates

BIO is expected to report earnings on Jul 25, 2024.

WST is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (-3.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BIO with price predictions.
OPEN
A.I.dvisor published
a Summary for WST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
WST($29B) has a higher market cap than BIO($9.79B). WST has higher P/E ratio than BIO: WST (50.25) vs BIO (3.64). WST YTD gains are higher at: 7.217 vs. BIO (-9.920). WST has higher annual earnings (EBITDA): 844M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. WST (854M). WST has less debt than BIO: WST (309M) vs BIO (1.41B). WST has higher revenues than BIO: WST (2.95B) vs BIO (2.67B).
BIOWSTBIO / WST
Capitalization9.79B29B34%
EBITDA-654.76M844M-78%
Gain YTD-9.9207.217-137%
P/E Ratio3.6450.257%
Revenue2.67B2.95B91%
Total Cash1.61B854M188%
Total Debt1.41B309M455%
FUNDAMENTALS RATINGS
BIO vs WST: Fundamental Ratings
BIO
WST
OUTLOOK RATING
1..100
5252
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10027
SMR RATING
1..100
9246
PRICE GROWTH RATING
1..100
6453
P/E GROWTH RATING
1..100
8153
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (77) in the Medical Specialties industry is in the same range as WST (85). This means that BIO’s stock grew similarly to WST’s over the last 12 months.

WST's Profit vs Risk Rating (27) in the Medical Specialties industry is significantly better than the same rating for BIO (100). This means that WST’s stock grew significantly faster than BIO’s over the last 12 months.

WST's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for BIO (92). This means that WST’s stock grew somewhat faster than BIO’s over the last 12 months.

WST's Price Growth Rating (53) in the Medical Specialties industry is in the same range as BIO (64). This means that WST’s stock grew similarly to BIO’s over the last 12 months.

WST's P/E Growth Rating (53) in the Medical Specialties industry is in the same range as BIO (81). This means that WST’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOWST
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 1 day ago
55%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 1 day ago
56%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 1 day ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
View a ticker or compare two or three
Ad is loading...
BIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
WSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPW4.990.22
+4.61%
Medical Properties Trust
ECX1.650.05
+3.12%
ECARX Holdings
TPHS0.14N/A
+1.42%
Trinity Place Holdings
CRVO25.250.25
+1.00%
CervoMed
PNR78.48-0.47
-0.60%
Pentair plc

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with BRKR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
-0.65%
BRKR - BIO
73%
Closely correlated
-1.13%
RVTY - BIO
71%
Closely correlated
+0.27%
MTD - BIO
57%
Loosely correlated
-2.46%
TMO - BIO
55%
Loosely correlated
-1.32%
DHR - BIO
53%
Loosely correlated
-0.40%
More

WST and

Correlation & Price change

A.I.dvisor indicates that over the last year, WST has been loosely correlated with EW. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if WST jumps, then EW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WST
1D Price
Change %
WST100%
-0.01%
EW - WST
42%
Loosely correlated
-0.91%
IDXX - WST
40%
Loosely correlated
-0.09%
STVN - WST
39%
Loosely correlated
-1.59%
IQV - WST
38%
Loosely correlated
-0.04%
DHR - WST
38%
Loosely correlated
-1.27%
More